Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 3.750% 2/0
-
Market price (% of par)
-
42.95%
-
Total 13F principal
-
$314,008,000
-
Principal change
-
-$1,706,000
-
Total reported market value
-
$135,817,000
-
Number of holders
-
20
-
Value change
-
-$933,943
-
Number of buys
-
3
-
Number of sells
-
5
Institutional Holders of NOVAVAX INC - NOTE 3.750% 2/0 as of Q2 2017
As of 30 Jun 2017,
NOVAVAX INC - NOTE 3.750% 2/0 was held by
20 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$314,008,000
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, Davidson Kempner Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, WHITEBOX ADVISORS LLC, AMERIPRISE FINANCIAL INC, ANGELO GORDON & CO., L.P., LAZARD ASSET MANAGEMENT LLC, and SYMPHONY ASSET MANAGEMENT LLC.
This page lists
20
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.